Novartis celebrates 21st annual Community Partnership Day with over 24,500 associates volunteering in their local communities
- Community Partnership Day symbolizes the company's commitment to improving people's lives and serving our local communities
- Follow the excitement with #NovartisCPD2017 and #proudmoments2017 via the Novartis Facebook, Twitter, Instagram and LinkedIn channels
Basel, May 11, 2017 - Today, in celebration of their 21st annual Community Partnership Day, more than 24,500 Novartis associates across six continents and 52 countries are making a difference in the communities where they live and work. Novartis associates volunteering their time to support social institutions and nonprofit organizations represents more than 187,000 hours of combined community service.
"Community Partnership Day demonstrates the massive potential for good that we can achieve on a global scale when we unite to lend a helping hand to people who need our support," said Joe Jimenez, CEO of Novartis.
"Associate volunteering is a key component of our strategic commitment to corporate responsibility, adds Juergen Brokatzky-Geiger, Head of Corporate Responsibility. "It offers a huge opportunity for our associates to leverage their strengths and skills to deliver on our mission of discovering new ways to improve and extend people's lives."
In Switzerland, more than 3,000 associates are volunteering across 60 communities, with activities ranging from helping people with disabilities, assisting hospitals and schools, to performing landscaping activities and restoring nature habitats.
In the United States, over 4,500 associates are volunteering with elementary schools, libraries, soup kitchens, women's shelters and senior citizen homes, as well as running food and blood drives.
In Asia, more than 5,000 associates are volunteering across a number of countries, including China, India, Indonesia, Vietnam and Singapore, to assist with free health screenings, participate in blood drives and provide services to local hospitals and orphanages.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis
For Novartis multimedia content, please visit www.novartis.com/news/media-library
For questions about the site or required registration, please contact email@example.com
# # #
Novartis Media Relations
Central media line: +41 61 324 2200
| Eric Althoff |
Novartis Global Media Relations
+41 61 324 7999 (direct)
+41 79 593 4202 (mobile)
Novartis Investor Relations
Central investor relations line: +41 61 324 7944
|Samir Shah||+41 61 324 7944||Richard Pulik||+1 212 830 2448|
|Pierre-Michel Bringer||+41 61 324 1065||Cory Twining||+1 212 830 2417|
|Thomas Hungerbuehler||+41 61 324 8425|
|Isabella Zinck||+41 61 324 7188|